Related Experiment Video

Updated: Aug 27, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Precision medicine for advanced breast cancer

Karen O'Leary

    Nature Medicine
    |September 27, 2022
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    Breast cancerCancer therapyGenomicsTargeted therapies

    More Related Videos

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.4K
    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
    08:26

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

    Published on: February 23, 2024

    2.1K

    Related Experiment Videos

    Last Updated: Aug 27, 2025

    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
    07:45

    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

    Published on: May 18, 2020

    6.2K
    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.4K
    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
    08:26

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

    Published on: February 23, 2024

    2.1K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    5.0K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    5.0K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.8K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Histological aging signatures for monitoring tissue-specific aging and disease.

    Nature medicine·2026

    How to build an AI-driven digital organism.

    Nature medicine·2026

    First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

    Nature medicine·2026

    Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

    Nature medicine·2026

    Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

    Nature medicine·2026

    Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

    Nature medicine·2026

    Control of Intraocular Metastases of ALK-Rearranged Non-Small Cell Lung Cancer with Sequential Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: A Report of 2 Cases and Review of the Literature.

    Case reports in oncology·2026

    TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.

    iScience·2026

    Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition.

    iScience·2026

    Hierarchical ROS-scavenging hydrogel system for coordinating the modulation of RGC necroptosis and oxidative stress in an acute glaucoma model.

    Bioactive materials·2026

    Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?

    Cureus·2026

    Arctigenin discovered by high-throughput screening ameliorates doxorubicin-induced cardiotoxicity as a novel natural KEAP1-NRF2 inhibitor.

    Journal of pharmaceutical analysis·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us